With a TSH of 1.52 mIU/L and total T4 of 5.1 µg/dL while taking levothyroxine 75 µg daily and liothyronine 10 µg daily, should I continue this thyroid replacement regimen?

Your Current Thyroid Regimen Needs Adjustment - The Total T4 is Too Low

Your total T4 of 5.1 µg/dL is significantly below the normal reference range (approximately 5.0-12.0 µg/dL), indicating you are biochemically under-replaced despite a normal TSH of 1.52 mIU/L. This discordance between TSH and T4 levels while on combination therapy requires immediate dose adjustment, specifically an increase in your levothyroxine component.

The Core Problem: Inadequate T4 Replacement

Your combination therapy of levothyroxine 75 µg + liothyronine 10 µg is producing an abnormal thyroid hormone profile:

• TSH 1.52 mIU/L: Within normal range (0.4-4.12 mIU/L) 1
• Total T4 5.1 µg/dL: Below normal range (typically 5.0-12.0 µg/dL)

This pattern suggests the liothyronine is suppressing your TSH adequately, but you lack sufficient T4 substrate. The guidelines emphasize that when serum TSH is within the normal range, free T4 should also be in the normal range 1. Your low total T4 indicates this is not the case.

Why This Matters for Your Health

The combination of normal TSH with low T4 creates several concerns:

1. Tissue-level hypothyroidism: Despite normal TSH, your peripheral tissues may not have adequate thyroid hormone, particularly in organs that rely on local T4-to-T3 conversion 1

2. Pregnancy risk: If you are a woman of childbearing age, low T4 levels are particularly problematic. Guidelines explicitly state that desiccated thyroid and L-thyroxine/L-triiodothyronine combinations, which cause lowering of serum T4 levels, should not be used during pregnancy 1

3. Suboptimal replacement: Your current regimen is not achieving the physiologic balance seen in euthyroid individuals 2

Recommended Action Plan

Immediate Steps:

Increase your levothyroxine dose by 12.5-25 µg daily (to 87.5-100 µg total) while maintaining the liothyronine 10 µg 1. The guideline recommends increment changes of 12.5-25 µg/d for dose adjustments 1.

Monitoring Schedule:

• Recheck TSH and total T4 (or free T4) in 6-8 weeks after the dose increase 1
• Target TSH: 0.3-2.0 mIU/L range 3
• Target total T4: Mid-to-upper normal range (approximately 8-11 µg/dL)

Critical Caveats:

The ratio of your combination therapy matters. Your current regimen has an L-T4/L-T3 ratio of approximately 7.5:1 by weight (75 µg ÷ 10 µg). After increasing levothyroxine to 100 µg, this would improve to 10:1, which is closer to the recommended 13:1 to 20:1 ratio 4. The physiologic ratio in desiccated thyroid is approximately 4:1, but synthetic combinations should use higher ratios 1.

Why Combination Therapy Requires Special Attention

The evidence shows that combination L-T4/L-T3 therapy creates different thyroid hormone distributions than L-T4 monotherapy or the euthyroid state 2. Specifically:

• Combination therapy tends to produce lower TSH for any given T4 level compared to untreated individuals 2
• The T3 component suppresses TSH more potently, potentially masking inadequate T4 replacement
• Only 43.8% of patients on levothyroxine achieve TSH within the reference range, compared to 90.3% of untreated individuals 2

Long-term Considerations

Is Combination Therapy Right for You?

The most recent guidelines and consensus statements indicate that L-T4 monotherapy remains the standard treatment 4. Combination therapy should only be considered as experimental in specific circumstances 3, 4:

• Persistent symptoms despite adequate L-T4 monotherapy with TSH 0.3-2.0 mIU/L for 3-6 months
• After excluding other comorbidities and autoimmune conditions
• As a time-limited trial (3 months) with clear endpoints 4

If you were started on combination therapy without first optimizing L-T4 monotherapy, this represents a deviation from guideline-recommended care 3, 4.

Monitoring for Overtreatment

Once your dose is adjusted, watch for signs of overtreatment, which carries significant risks:

• Cardiovascular effects: Atrial fibrillation (especially if elderly), rapid heartbeat, chest pain 1
• Skeletal effects: Accelerated bone loss (particularly concerning for postmenopausal women) 1
• Other symptoms: Tremors, anxiety, heat intolerance, weight loss 5

The guidelines emphasize that 20% of patients treated with thyroid hormone are overtreated, with principal adverse consequences being cardiovascular and skeletal 1.

Practical Medication Management

Dosing Instructions:

• Take levothyroxine 30-60 minutes before breakfast with water on an empty stomach 1, 5
• Take liothyronine in two divided doses daily (e.g., 5 µg twice daily) to minimize T3 level fluctuations 6, 4
• Avoid taking within 4 hours of iron, calcium supplements, or antacids 5

Storage:

Store both medications at 20-25°C (68-77°F), protected from light and moisture 1, 5

The Bottom Line

Your low total T4 indicates biochemical under-replacement that requires correction regardless of your normal TSH. Increase your levothyroxine dose and recheck labs in 6-8 weeks. If you continue to have persistent symptoms after achieving normal T4 levels with TSH 0.3-2.0 mIU/L, then reassess whether combination therapy is truly beneficial or whether L-T4 monotherapy at an optimized dose would be more appropriate 3, 4.